Re:FDA clears blood test to aid evaluation for Alzheimer's d...
by avgDev on Monday August 24, 2026 @12:13PM
(#49421912)
We can also test for PSEN1, which is 100% accurate in determining early onset alzheimer's disease, quite a it more expensive, so unreasonable as a screening tool unfortunately.
[ Parent
| on HN ]
Re:FDA clears blood test to aid evaluation for Alzheimer's d...
by brianleb on Monday August 24, 2026 @01:09PM
(#49422832)
I am skeptical of 100% anything, so did some looking:
>>Mutations in PSEN1 and APP are associated with complete penetrance, meaning that all individuals who have a PSEN1 or APP mutation will develop AD if they live a normal lifespan [1]
and
>>[Age-of-onset] Usually 40s or early 50s (range 30s-early 60s) [2]
Note that this is only for early-onset Alzheimer's, representing ~5% of all Alzheimer's.
>>Our study showed that the rate of EOAD in AD is 5.5%, not 1-2% as usually demonstrated. And our results indicated that the rate in developed countries was relative higher than in developing countries [3]
[1]https://pmc.ncbi.nlm.nih.gov/articles/PMC3326653/
[2]https://www.ncbi.nlm.nih.gov/books/NBK1161/table/alzheimer.T...